The coverage in the peer-reviewed journal (which is actually a big deal because peer-reviewed journals are where doctors and scientists will review aka. argue whether there are issues with anything published) is actually quite significant. Essentially it is a massive advertisement to the medical industry saying , look at these new findings. And the news isn't all old, updated numbers, FDA fast track designation, orphan drug designation, these are not old news... while you might be right about P&D, this could also be bought out or find a partnership because of the peer-reviewed publication.coverage.
GLTA!
News 
Market Data 
Discover 
